- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HHS Seeks $600 Million For Health Law Enrollment Efforts
Just in case Congress doesn't pass President Barack Obama's fiscal 2015 budget plan, officials at the Department of Health and Human Services say they have other options for finding the money they need to implement the health care law.
Just in case Congress doesn’t pass President Barack Obama’s fiscal 2015 budget plan, officials at the Department of Health and Human Services say they have other options for finding the money they need to implement the health care law.
Copies of U.S. President Barack Obama's fiscal year 2015 budget are shown for sale at the Government Printing Office in Washington (Photo by Win McNamee/Getty Images).
The law is expected to generate $1.2 billion in user fees—including those on health insurers who participate in its online marketplaces, or exchanges. The administration’s budget requests an additional $600 million to help run the federal marketplace, call centers and other outreach efforts, said Ellen Murray, assistant HHS secretary for financial resources.
If Congress doesn’t agree, she said, the secretary’s office has the authority to transfer funds from existing accounts, or to tap the agency’s non-recurring expense fund, which allows the agency to take money from expired accounts and use it for information technology and other capital investments.
Read the full story here: http://bit.ly/MQjwMG
Source: Kaiser Health News
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
